Celldex Therapeutics (CLDX) PT Raised to $72 at Guggenheim
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $41.92 --0%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $72.00 (from $63.00) while maintaining a Buy rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- Affin Bank Bhd. (ABANK:MK) PT Lowered to MYR2.40 at Nomura/Instinet
- Sansan Inc (4443:JP) PT Raised to JPY2,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
